[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 2013

The Use of Aprepitant in Brachioradial Pruritus

Author Affiliations

Author Affiliations: Department of Dermatology, Stanford University School of Medicine, Stanford, California.

JAMA Dermatol. 2013;149(5):627-628. doi:10.1001/jamadermatol.2013.170

Brachioradial pruritus (BRP) is characterized by intractable itching localized to the dorsolateral aspects of the arms.1,2 Aprepitant (Emend; Merck & Co Inc), approved in 2003 for chemotherapy-induced nausea and vomiting, has been used successfully to treat patients with chronic pruritus,3,4 but to our knowledge, its use in BRP has not yet been reported.

First Page Preview View Large
First page PDF preview
First page PDF preview